Protara Therapeutics, Inc. (TARA)
NASDAQ: TARA · Real-Time Price · USD
4.120
+0.120 (3.00%)
At close: Jun 26, 2026, 4:00 PM EDT
4.200
+0.080 (1.94%)
After-hours: Jun 26, 2026, 7:31 PM EDT
Protara Therapeutics Employees
Protara Therapeutics had 46 employees as of December 31, 2025. The number of employees increased by 18 or 64.29% compared to the previous year.
Employees
46
Change (1Y)
18
Growth (1Y)
64.29%
Revenue / Employee
n/a
Profits / Employee
-$1,376,239
Market Cap
231.56M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Karyopharm Therapeutics | 228 |
| Fate Therapeutics | 161 |
| Coherus Oncology | 145 |
| Voyager Therapeutics | 141 |
| Foghorn Therapeutics | 106 |
| Orchestra BioMed Holdings | 86 |
| Anavex Life Sciences | 34 |
| Whitehawk Therapeutics | 29 |
TARA News
- 4 weeks ago - Protara Therapeutics Transcript: 7th Annual Oncology Innovation Summit: Insights for ASCO & EHA - Transcripts
- 5 weeks ago - Protara Therapeutics to Present at the TD Cowen 7th Annual Oncology Innovation Summit: Insights for ASCO & EHA - GlobeNewsWire
- 5 weeks ago - Protara Therapeutics price target raised to $28 from $25 at Oppenheimer - TheFly
- 5 weeks ago - Protara Therapeutics Transcript: KOL event - Transcripts
- 5 weeks ago - Protara Therapeutics Slides: KOL event - Filings
- 5 weeks ago - Protara Therapeutics to Host Virtual Investor Webinar to Discuss TARA-002 for Lymphatic Malformations on Tuesday, May 19, 2026 - GlobeNewsWire
- 6 weeks ago - Protara announces updated 12-month data from Cohort A of ADVANCED-2 trial - TheFly
- 6 weeks ago - Protara Therapeutics Announces Positive Updated 12-Month Data Demonstrating Durable Responses in the Fully Enrolled BCG-Naïve Cohort of the Ongoing Phase 2 ADVANCED-2 Trial of TARA-002 in NMIBC - GlobeNewsWire